Literature DB >> 27201894

Patient Reported Utilities In First-Line Advanced Or Metastatic Melanoma: Analysis Of Trial CA184-024.

J Porter1, D Lee1, N Hertel2, A J Hatswell1.   

Abstract

Entities:  

Year:  2014        PMID： 27201894     DOI： 10.1016/j.jval.2014.08.1900

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England.

Authors:  Yang Meng; Nadine Hertel; John Ellis; Edith Morais; Helen Johnson; Zoe Philips; Neil Roskell; Andrew Walker; Dawn Lee
Journal:  Eur J Health Econ       Date:  2018-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.